Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675956 · ClinicalTrials.gov registry record · NA
Acute Nerve Stimulation For Enhancing Human and Cognitive Performance
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT05675956 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 35 participants.
The verdict
NCT05675956, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a wearable device's effect on performance in tactical populations with a history of concussion. The main question it aims to answer is the effectiveness of the device on modulate physiological and cognitive function. The physiological function will be derived from metrics of heart rate variability and blood-based biomarkers, whilst human performance will be evaluated using tasks that assess cognitive domains of executive function, reaction time, and memory.
Interventions
- DEVICE Experimental group with 100% intensity setting on Apollo Neuro device
- DEVICE Active Comparator group with 10% intensity setting on the Apollo Neuro device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2023-01-15 |
| Est. Completion | 2024-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675956
The ClinicalTrials.gov registry entry for NCT05675956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental group with 100% intensity setting on Apollo Neuro device is the first listed.
NCT05675956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05675956 about?
NCT05675956 is a clinical study titled "Acute Nerve Stimulation For Enhancing Human and Cognitive Performance". The goal of this clinical trial is to test a wearable device's effect on performance in tactical populations with a history of concussion. The main question it aims to answer is the effectiveness of the device on modulate physiological and cognitive function. The physiological function will be deri...
What is the current status of trial NCT05675956?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2023-01-15. Estimated completion is 2024-03-27.
What interventions are being tested in trial NCT05675956?
The interventions under investigation include: Experimental group with 100% intensity setting on Apollo Neuro device (DEVICE), Active Comparator group with 10% intensity setting on the Apollo Neuro device (DEVICE).
Who is sponsoring clinical trial NCT05675956?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.